Healthcare Scan
Healthcare Scan
Data as-of 2026-07-31 close, except SYK which carries a 2026-07-30 bar — read that row as one session stale.
The large-cap complex cooled together: ABT dropped out of overbought (RSI 73.3 → 67.3) alongside AMGN (72.8 → 64.9), while TMO held closer to flat (70.3 → 68.8) — the same unwind visible in this session's biotech cut. DXCM spiked the other way, RSI 54.6 → 68.6 on an 11.95% single-day move, and GH climbed 45.8 → 62.0 on the largest three-month gain in the cut (+84.9%, change3m). ISRG relapsed back under 40 (42.4 → 39.9), giving back last scan's recovery — the identical ticker showing the identical relapse in the biotech cut.
Source: healthcare.json (the broader 21-name universe, not the narrower healthcare-scan.json cut). Latest bar 2026-07-31 for every name in this cut except SYK (2026-07-30). Prior scan: 2026-07-28-healthcare-scan.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Broad cooling mirrors the biotech and defensive cuts — ABT and AMGN both dropped out of overbought, DXCM and GH both spiked, and ISRG relapsed back under RSI 40 after last scan's recovery |
| Leaders | TMO (RSI 68.8, holds near the top after cooling only slightly); DXCM (68.6, spiked on an outsized move, +21.2% 30D); ABT (67.3, cooled out of overbought but still the strongest large-cap read) |
| Laggards | ISRG (RSI 39.9, relapsed back under 40, "collapse" regime persists); MRNA (40.9, still -24.4% over 30 days); HROW (42.5, still no confirmed floor) |
| Key insight | The prior scan's overbought cluster (ABT, AMGN, TMO) unwound almost in unison with the biotech cut's large-cap complex — only TMO still sits above RSI 68, and even that's cooled from 70.3 |
What's Going On
The large-cap complex cooled together. ABT's RSI fell from 73.3 to 67.3 and AMGN's from 72.8 to 64.9 — both dropping out of overbought after crossing the line last scan — while TMO held closer to flat (70.3 → 68.8). JNJ (65.2 → 52.3), CVS (66.3 → 50.5), and MRK (63.3 → 58.9) all posted comparably large single-scan drops without any regime downgrade — all three remain in an "uptrend" regime with a golden-cross trend label, just pulled back from a stronger prior read.
DXCM and GH were the session's two outsized movers in the other direction. DXCM's RSI spiked from 54.6 to 68.6 on an 11.95% single-day move (change1d per healthcare.json), +21.19% over 30 days — the identical move that shows up in this session's biotech cut for the identical ticker. GH climbed from 45.8 to 62.0, +9.95% over the week and +84.92% over three months (change3m) — the largest three-month gain anywhere in this cut.
ISRG relapsed. RSI fell back from 42.4 to 39.9, giving back last scan's recovery out of the oversold band — the same relapse that shows up in the biotech cut for this identical ticker. The regime classifier still reads "collapse," and the trend remains strong-down DC.
MRNA and HROW, the sector's other two previously-weak names, stayed roughly flat without resolving either way: MRNA moved 40.3 → 40.9 (still -24.39% over 30 days), HROW moved 43.5 → 42.5 (still not confirmed one way or the other). SYK's bar is one session stale (2026-07-30) — read that row as a snapshot from Thursday's close, not Friday's.
What Changed Since Prior Scan (2026-07-28)
- ABT and AMGN both dropped out of overbought. ABT: 73.3 → 67.3. AMGN: 72.8 → 64.9. TMO held closer to flat, 70.3 → 68.8.
- DXCM spiked on an outsized single day. RSI 54.6 → 68.6, +11.95% in one session, +21.2% over 30 days — the same move shared with this session's biotech cut.
- GH posted the largest 3-month gain in the cut. RSI 45.8 → 62.0, +84.9% over three months (change3m).
- ISRG relapsed back under 40. RSI 42.4 → 39.9, giving back its prior recovery; regime still "collapse."
- JNJ and CVS both cooled sharply. JNJ: 65.2 → 52.3. CVS: 66.3 → 50.5.
- MRNA and HROW stayed roughly flat, unresolved. MRNA: 40.3 → 40.9. HROW: 43.5 → 42.5.
- SYK's bar is one session stale (2026-07-30) this scan.
- Universe unchanged. Same 21 tickers as the July 28 cut — no composition change.
How To Read The Board
RSI measures how stretched a stock is over the past 14 sessions — under 30 is oversold, over 70 is overbought/extended. vs SMA20 is the price gap to the 20-day average. vs VWAP is the premium over the average price paid by current holders — a useful gut check on how much of a move is unrealized gain that could get sold into weakness. Trend combines direction/strength with a cross signal: GC (golden cross) is structurally healthier than DC (death cross). A stock whose RSI falls back under 40 while its regime classifier still reads "collapse" — like ISRG here — means the earlier recovery wasn't confirmed by the underlying structure; treat it as "watch," not "buy."
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | 3M% | 52wkHi% | Trend | vs VWAP |
|---|---|---|---|---|---|---|---|---|---|
| ISRG | $353.33 | 39.9 | -5.9% | +4.7% | -12.2% | -22.8% | -41.5% | strong-down DC | -24.0% |
| MRNA | $54.82 | 40.9 | -14.0% | +1.4% | -24.4% | +20.8% | -36.0% | weak-down GC | +38.4% |
| HROW | $38.77 | 42.5 | -8.1% | +0.8% | -9.8% | -5.2% | -29.3% | strong-down DC | -3.7% |
| LLY | $1,148.84 | 45.8 | -3.0% | -4.0% | -3.6% | +19.5% | -8.1% | strong-up GC | +22.9% |
| UNH | $414.40 | 47.0 | -2.3% | -1.5% | -2.9% | +13.0% | -10.2% | strong-up GC | +28.2% |
| VRTX | $477.10 | 48.4 | -2.0% | -0.1% | -4.2% | +12.5% | -10.6% | strong-up GC | +8.6% |
| GILD | $130.21 | 48.7 | -1.5% | +0.7% | +3.4% | -0.4% | -17.2% | weak-up DC | +2.8% |
| BIIB | $202.95 | 50.2 | +0.1% | +0.4% | -3.2% | +8.5% | -7.6% | strong-up GC | +17.8% |
| CVS | $104.43 | 50.5 | -1.2% | -3.1% | +0.3% | +28.0% | -5.7% | strong-up GC | +29.2% |
| ZTS | $77.29 | 51.1 | +2.3% | +2.6% | +7.4% | -31.8% | -51.8% | weak-up DC | -28.8% |
| JNJ | $256.35 | 52.3 | -0.6% | -2.7% | +0.9% | +13.5% | -6.8% | strong-up GC | +19.6% |
| PFE | $25.01 | 57.2 | +2.7% | +1.9% | +6.6% | -1.8% | -13.0% | up DC | +2.5% |
| MDT | $85.39 | 58.3 | +2.4% | +2.6% | +7.8% | +7.7% | -19.7% | weak-up DC | -3.4% |
| MRK | $130.20 | 58.9 | +2.3% | -0.7% | +3.9% | +16.9% | -3.6% | strong-up GC | +26.2% |
| GH | $161.99 | 62.0 | +4.5% | +10.0% | -5.1% | +84.9% | -8.3% | strong-up GC | +64.6% |
| VEEV | $203.78 | 62.1 | +5.2% | +9.4% | +10.6% | +18.8% | -34.4% | weak-up DC | -0.1% |
| SYK* | $348.04 | 62.6 | +6.3% | +9.1% | +10.6% | +10.7% | -13.4% | up DC | +1.7% |
| AMGN | $385.16 | 64.9 | +3.9% | +2.4% | +6.6% | +17.7% | -3.2% | strong-up GC | +16.8% |
| ABT | $105.70 | 67.3 | +6.9% | +2.6% | +15.5% | +19.0% | -23.1% | weak-up DC | -0.5% |
| DXCM | $83.45 | 68.6 | +11.9% | +16.7% | +21.2% | +36.0% | -1.5% | strong-up GC | +22.0% |
| TMO | $574.30 | 68.8 | +5.9% | +1.1% | +11.9% | +22.5% | -10.8% | up DC | +10.5% |
*SYK carries a 2026-07-30 bar — one session stale; read this row with that caveat.
Tier Analysis
Extreme Oversold (RSI < 25)
None.
Oversold band (RSI 25-40)
ISRG (39.9) — the cut's only sub-40 print, just barely inside the line after relapsing from last scan's recovery.
RSI 40+ (everyone else)
- Cooling band: MRNA, HROW, LLY, UNH, VRTX, GILD, BIIB. None broken further, none confirmed a floor.
- Basing band: CVS, ZTS, JNJ, PFE, MDT, MRK. The cleanest zone in the cut — none extended, none damaged.
- Momentum band: GH, VEEV, SYK, AMGN, ABT, DXCM, TMO. Only TMO and DXCM sit above RSI 68 this scan — down from three names (ABT, AMGN, TMO) above 70 last time.
Entry Zones
| Stock | Price | Zone | RSI | 30D% | Setup |
|---|---|---|---|---|---|
| GILD | $130.21 | <$127.48 (support shelf) | 48.7 | +3.4% | Cooled hard from last scan's read, clean structure |
| PFE | $25.01 | <$24.83 (support shelf) | 57.2 | +6.6% | Steady climb, not extended |
| ABT | $105.70 | <$104.57 (support shelf) | 67.3 | +15.5% | Cooled out of overbought but still close to its own shelf |
| DXCM | $83.45 | <$73.87 (support shelf) | 68.6 | +21.2% | Spiked on an outsized single day; let the move settle before entering |
| ISRG | $353.33 | No support shelf identified | 39.9 | -12.2% | Relapsed back under 40; regime still "collapse," no confirmed floor |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 📈 ACCUMULATE | GILD, PFE | Cleanest reads in the cut, cooled but not broken, no extension |
| 🔒 HOLD | MRK, JNJ, LLY, UNH, CVS, VRTX, BIIB, AMGN, ABT, TMO | Uptrend/pullback regime, cooled from a stronger prior read; don't chase but don't sell |
| 🔍 WATCH | MRNA, HROW, ZTS, VEEV, GH, DXCM, SYK, MDT | Mixed signals — fresh spikes (DXCM, GH) need to settle, others (MRNA, HROW, ZTS, MDT) unresolved from a weak or mismatched prior read, SYK's bar is stale |
| ❌ AVOID / FALLING KNIFE | ISRG | "Collapse" regime persists despite the relapse-adjacent RSI |
What To Watch Next
- ABT and AMGN both dropped out of overbought together — does the large-cap complex keep resetting, or does it re-extend from here?
- DXCM and GH both posted outsized single-scan spikes — do those moves hold, or do they give back the way the prior overbought cluster just did?
- ISRG relapsed back under RSI 40 for the second scan running (also visible in the biotech cut) — does the "collapse" regime read finally get confirmed, or does it bounce again?
- SYK's bar is one session stale — does the next refresh show it kept pace with the rest of the cut's cooling, or diverged?
Sources
- Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-31 close — healthcare.
Related
10 eventsNo direct external sources are attached to this read.